Literature DB >> 32484098

Expression and Purification of Tetanus Toxin Fragment C in Escherichia coli BL21(DE3).

Pengdi Chai1,2,3, Xiuying Pu1,2, Jianqiang Li3, Xiaoyu Xia1,2,3, Jun Ge3, Amiao Luo1,2, Hui Su1,2, Weijie Zhang1,2, Jianzhong Ma1,2.   

Abstract

BACKGROUND: Tetanus is an infectious disease caused by Clostridium secreting tetanus toxin in anaerobic environment. The fragment C of Tetanus toxin (TTc) has been widely studied as a candidate vaccine to replace the existing tetanus toxoid vaccine.
OBJECTIVE: In this study, we established a simple method to purify recombinant protein TTc with ion-exchange chromatography from Escherichia coli expression systems.
METHODS: The TTc gene sequence was cloned into pET26b (+) vector and transferred to E. coli BL21 (DE3) for expression. The fermentation conditions (IPTG concentration, Induction temperature, Induction time) were optimized to obtain more soluble proteins. The soluble proteins were purified by Anion exchange chromatography and Cation exchange chromatography. The sequence of columns in the purification process was discussed. Finally, the stability of purified TTc protein were determined, the secondary structure of the purified TTc protein was determined by circular dichroism. The molecular weight of the purified TTc protein was determined by liquid chromatograph- mass spectrometer. Furthermore, we verified the immunogenicity of the purified protein in mice.
RESULTS: The purity of TTc improved from 34% to 88% after the first anion exchange column, and the final yield of recombinant TTc (purity > 95%) can reach 84.79% after the following cation exchange chromatography. The recombinant TTc had a molecular weight of 51.737 KDa, was stable at 4 °C and weak alkaline environment, was a β-sheet secondary structure, and had strong immunogenicity.
CONCLUSION: The purification method we developed might be an efficient method for the industrial production of tetanus recombinant TTc vaccine. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Tetanus; immunogenicity; molecular weight; purification; tetanus toxin; the fragment C

Mesh:

Substances:

Year:  2020        PMID: 32484098     DOI: 10.2174/0929866527666200528113327

Source DB:  PubMed          Journal:  Protein Pept Lett        ISSN: 0929-8665            Impact factor:   1.890


  2 in total

1.  The recombinant protein combined vaccine based on the fragment C of tetanus toxin and the cross-reacting material 197.

Authors:  Pengdi Chai; Xiuying Pu; Jun Ge; Sulin Ren; Xiaoyu Xia; Amiao Luo; Shiwei Wang; Xiaodong Wang; Jianqiang Li
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-29       Impact factor: 4.813

Review 2.  Tetanus Toxin Fragment C: Structure, Drug Discovery Research and Production.

Authors:  Caroline Bayart; Angélique Mularoni; Nada Hemmani; Soumeya Kerachni; Joachim Jose; Patrice Gouet; Joseph Paladino; Marc Le Borgne
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.